Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06469242 · ClinicalTrials.gov registry record · NA
Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT06469242: Completed NA study, sponsored by Alcon Research.
NCT06469242 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06469242, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the on-eye multifocal clinical performance of investigational LID233309 contact lenses and Oasys multifocal (MF) contact lenses in a daily wear dispensing trial.
Primary Outcome
Visual Acuity (VA) was assessed at a distance of 4 meters with both eyes together (binocular) under high contrast, high illumination lighting with study lenses in place. VA was measured using letter charts and recorded in the logarithm of the minimum angle of resolution (LogMAR). A LogMAR value of 0 equates to 20/20 Snellen VA (normal distance eyesight), with negative LogMAR values representing better than 20/20 VA. The LogMAR VA scale ranges from -0.30 (20/10 Snellen) to 1.00 (20/200 Snellen).
Interventions
- DEVICE Serafilcon A multifocal contact lenses
- DEVICE Senofilcon A multifocal contact lenses
- DEVICE CLEAR CARE® Cleaning & Disinfecting Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2024-07-18 |
| Est. Completion | 2024-10-08 |
| Phase | NA |
What the finished NCT06469242 record still lists
NCT06469242 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 3 interventions - of which Serafilcon A multifocal contact lenses is the first listed.
NCT06469242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06469242 about?
NCT06469242 is a clinical study titled "Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses". The purpose of this study is to evaluate the on-eye multifocal clinical performance of investigational LID233309 contact lenses and Oasys multifocal (MF) contact lenses in a daily wear dispensing trial.
What is the current status of trial NCT06469242?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2024-07-18. Estimated completion is 2024-10-08.
What interventions are being tested in trial NCT06469242?
The interventions under investigation include: Serafilcon A multifocal contact lenses (DEVICE), Senofilcon A multifocal contact lenses (DEVICE), CLEAR CARE® Cleaning & Disinfecting Solution (DEVICE).
Who is sponsoring clinical trial NCT06469242?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06469242's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI